Enzo Claims Victory in Markman Ruling in ABI Suit; Licenses Six More RNA-Amplification Patents | GenomeWeb
This article has been updated to clarify the fact that the ruling was not sent for immediate appeal to the Federal Circuit, as originally reported, but was certified for immediate repeal.
 
NEW YORK (GenomeWeb News) - Enzo Biochem said today that a US District Court has ruled in its favor in the claims-construction phase of an ongoing patent-infringement suit against Applera's Applied Biosystems group and its Tropix subsidiary.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.